Homestead Advisers Corp Has $60.55 Million Stock Holdings in Cigna Group $CI

Homestead Advisers Corp trimmed its stake in shares of Cigna Group (NYSE:CI) by 1.9% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 210,062 shares of the health services provider’s stock after selling 4,000 shares during the quarter. Homestead Advisers Corp owned about 0.08% of Cigna Group worth $60,550,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Pathway Financial Advisers LLC grew its stake in Cigna Group by 2.3% during the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after buying an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. lifted its holdings in shares of Cigna Group by 17.7% during the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock worth $65,000 after acquiring an additional 34 shares during the period. HM Payson & Co. boosted its position in shares of Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after acquiring an additional 35 shares in the last quarter. Carr Financial Group Corp increased its stake in Cigna Group by 5.3% in the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after acquiring an additional 36 shares during the last quarter. Finally, Natural Investments LLC raised its position in Cigna Group by 2.0% during the third quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock valued at $531,000 after purchasing an additional 36 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CI. Wall Street Zen lowered Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, January 24th. Wolfe Research reduced their price objective on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. TD Cowen set a $333.00 target price on Cigna Group in a research note on Monday, December 15th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. Finally, Wells Fargo & Company decreased their price target on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a research note on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $323.84.

Cigna Group Stock Performance

CI stock opened at $271.97 on Thursday. The firm has a market cap of $72.65 billion, a PE ratio of 12.00, a price-to-earnings-growth ratio of 0.98 and a beta of 0.27. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average price of $274.37 and a 200-day moving average price of $283.96. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.